Literature DB >> 16806755

Deformable liposomes and ethosomes: mechanism of enhanced skin delivery.

Mustafa M A Elsayed1, Ossama Y Abdallah, Viviane F Naggar, Nawal M Khalafallah.   

Abstract

Despite intensive research, the mechanisms by which vesicular systems deliver drugs into intact skin are not yet fully understood. In the current study, possible mechanisms by which deformable liposomes and ethosomes improve skin delivery of ketotifen under non-occlusive conditions were investigated. In vitro permeation and skin deposition behavior of deformable liposomes and ethosomes, having ketotifen both inside and outside the vesicles (no separation of free ketotifen), having ketotifen only inside the vesicles (free ketotifen separated) and having ketotifen only outside the vesicles (ketotifen solution added to empty vesicles), was studied using rabbit pinna skin. Results suggested that both the penetration enhancing effect and the intact vesicle permeation into the stratum corneum might play a role in improving skin delivery of drugs by deformable liposomes, under non-occlusive conditions, and that the penetration enhancing effect was of greater importance in case of ketotifen. Regarding ethosomes, results indicated that ketotifen should be incorporated in ethosomal vesicles for optimum skin delivery. Ethosomes were not able to improve skin delivery of non-entrapped ketotifen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806755     DOI: 10.1016/j.ijpharm.2006.05.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  55 in total

1.  Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Vivek Gupta; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2013-10-12       Impact factor: 9.776

2.  Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  AAPS PharmSciTech       Date:  2012-12-14       Impact factor: 3.246

3.  Lipid Vesicles for the Skin Delivery of Diclofenac: Cerosomes vs. Other Lipid Suspensions.

Authors:  Anahita Fathi-Azarbayjani; Kai Xin Ng; Yew Weng Chan; Sui Yung Chan
Journal:  Adv Pharm Bull       Date:  2015-03-05

4.  Nanosized ethosomes bearing ketoprofen for improved transdermal delivery.

Authors:  Manish K Chourasia; Lifeng Kang; Sui Yung Chan
Journal:  Results Pharma Sci       Date:  2011-10-13

5.  Topical photodynamic therapy using transfersomal aluminum phthalocyanine tetrasulfonate: in vitro and in vivo study.

Authors:  Kawser Kassab; Doaa Abd El Fadeel; Maha Fadel
Journal:  Lasers Med Sci       Date:  2013-01-05       Impact factor: 3.161

6.  Ligustrazine phosphate ethosomes for treatment of Alzheimer's disease, in vitro and in animal model studies.

Authors:  Jun Shi; Yiming Wang; Guoan Luo
Journal:  AAPS PharmSciTech       Date:  2012-03-14       Impact factor: 3.246

7.  Tocopheryl phosphate mixture (TPM) as a novel lipid-based transdermal drug delivery carrier: formulation and evaluation.

Authors:  Paul D Gavin; Mahmoud El-Tamimy; Hooi Hong Keah; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

8.  Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment.

Authors:  Rahul G S Maheshwari; Rakesh K Tekade; Piyoosh A Sharma; Gajanan Darwhekar; Abhishek Tyagi; Rakesh P Patel; Dinesh K Jain
Journal:  Saudi Pharm J       Date:  2011-10-31       Impact factor: 4.330

9.  Preparation and in vitro evaluation of ethosomal total alkaloids of Sophora alopecuroides loaded by a transmembrane pH-gradient method.

Authors:  Yan Zhou; Yuhui Wei; Huanxiang Liu; Guoqiang Zhang; Xin'an Wu
Journal:  AAPS PharmSciTech       Date:  2010-08-26       Impact factor: 3.246

10.  Preparation and ocular pharmacokinetics of ganciclovir liposomes.

Authors:  Yan Shen; Jiasheng Tu
Journal:  AAPS J       Date:  2007-12-07       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.